Back
Crinetics Pharmaceuticals Vs. iBio Industry Stock Comparison
Buy
60
CRNX
Crinetics Pharmaceuticals
Last Price:
59.53
Seasonality Move:
9.3%
Sell
31
IBIO
iBio
Last Price:
2.28
Seasonality Move:
-9.79%
Buy
60
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
- The current Crinetics Pharmaceuticals [CRNX] share price is $58.92. The Score for CRNX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- CRNX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
iBio (IBIO)
is a Sell
Is iBio a Buy, Sell or Hold?
- The current iBio [IBIO] share price is $2.32. The Score for IBIO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- IBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $58.92
The current trend is moderately bullish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
IBIO Stock Price Chart
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.35 | Buy |
| Relative Strength Index (14 RSI): | 58.51 | Buy |
| Chaikin Money Flow: | -780726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.69 - 59.83) | Buy |
| Bollinger Bands (100): | (48.73 - 56.63) | Buy |
IBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 37.42 | Sell |
| Chaikin Money Flow: | -187114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.55 - 2.87) | Sell |
| Bollinger Bands (100): | (1.84 - 2.54) | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.99 | Sell |
| 20-day SMA: | 58.26 | Buy |
| 50-day SMA: | 54.58 | Buy |
| 200-day SMA: | 48.24 | Buy |
| 8-day EMA: | 58.88 | Buy |
| 20-day EMA: | 57.69 | Buy |
| 50-day EMA: | 55.44 | Buy |
| 200-day EMA: | 47.9 | Buy |
IBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.55 | Sell |
| 20-day SMA: | 2.71 | Sell |
| 50-day SMA: | 2.36 | Sell |
| 200-day SMA: | 1.99 | Buy |
| 8-day EMA: | 2.54 | Sell |
| 20-day EMA: | 2.59 | Sell |
| 50-day EMA: | 2.45 | Sell |
| 200-day EMA: | 4 | Sell |
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.21 per share.
iBio Earnings Growth & IBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.
Crinetics Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
iBio Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||